Need help finding what you are looking for?
Contact Us
PUBLISHER: IMARC | PRODUCT CODE: 1800960
PUBLISHER: IMARC | PRODUCT CODE: 1800960
Multiple Sclerosis Therapies Market Report by Drug, Drug Type, Route of Administration, Distribution Channel, and Region 2025-2033
PUBLISHED:
PAGES: 120 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
The global multiple sclerosis therapies market size reached USD 27.9 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 38.8 Billion by 2033, exhibiting a growth rate (CAGR) of 3.52% during 2025-2033.
Multiple sclerosis (MS) refers to a chronic and inflammatory immune-mediated condition that can cause demyelination, axonal transection and neurodegeneration of the nerve cells in the spinal cord and brain. Some of the commonly used therapies include the administration of injectable, oral and infused medicines, muscle relaxants, antidepressants and physical therapy. The injectable medication, such as Interferon-beta and Glatiramer acetate, are administered under the skin or into the muscle; oral medications include Dimethyl fumarate, Teriflunomide and Cladribine; and infusion treatments include Ocrelizumab, Natalizumab and Alemtuzumab, which are administered intravenously. These medicines aid in managing the symptoms to minimize the frequency of the relapses and control the heart rate and blood pressure of the patient.
The increasing prevalence of relapsing-remitting multiple sclerosis (RRMS), primary-progressive MS (PPMS), secondary-progressive MS (SPMS) and progressive-relapsing MS (PRMS) across the globe, is one of the key factors driving the growth of the market. Furthermore, the rising geriatric population, which is more susceptible to such ailments, is providing a thrust to the market growth. Healthcare providers are widely using immunosuppressants that control autoimmune attacks and prevent relapses among patients suffering from MS. Additionally, various technological advancements, such as the development of innovative monoclonal bodies, immunomodulators, immunosuppressants and interferons for the effective treatment of MS, are acting as other major growth-inducing factors. Apart from this, governments of both the developed and emerging countries are launching campaigns to increase awareness regarding the available treatment alternatives among the masses, which, in turn, is creating a positive outlook for the market. Other factors, including extensive research and development (R&D) activities, along with the improvements in the healthcare infrastructure, are anticipated to drive the market further.
Key Market Segmentation:
Breakup by Drug:
- Immunomodulators
- Copaxone
- Avonex/Plegridy
- Gilneya
- Tysabri
- Betaseron/Extavia
- Tecifidera
- Rebif
- Ampyra
- Immunosuppressants
- Aubagio
- Lemtrada
- Ocrelizumab
- Zinbryta
Breakup by Drug Type:
- Biologic Drugs
- Small Molecule Drugs
Breakup by Route of Administration:
- Oral
- Injectable
- Intravenous
Breakup by Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Breakup by Region:
- North America
- United States
- Canada
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
Competitive Landscape:
The report has also analysed the competitive landscape of the market with some of the key players being Abbvie Inc., Bayer Aktiengesellschaft, Biogen Inc., Bristol-Myers Squibb Company, F. Hoffmann-La Roche AG (Roche Holding AG), GlaxoSmithKline Plc, Merck & Co. Inc., Novartis AG, Sanofi S.A. and Teva Pharmaceutical Industries Ltd.
Key Questions Answered in This Report:
- How has the global multiple sclerosis therapies market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global multiple sclerosis therapies market?
- What are the key regional markets?
- What is the breakup of the market based on the drug?
- What is the breakup of the market based on the drug type?
- What is the breakup of the market based on the route of administration?
- What is the breakup of the market based on the distribution channel?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global multiple sclerosis therapies market and who are the key players?
- What is the degree of competition in the industry?
Product Code: SR112025A2571
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Multiple Sclerosis Therapies Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Drug
- 6.1 Immunomodulators
- 6.1.1 Market Trends
- 6.1.2 Major Types
- 6.1.2.1 Copaxone
- 6.1.2.2 Avonex/Plegridy
- 6.1.2.3 Gilneya
- 6.1.2.4 Tysabri
- 6.1.2.5 Betaseron/Extavia
- 6.1.2.6 Tecifidera
- 6.1.2.7 Rebif
- 6.1.2.8 Ampyra
- 6.1.3 Market Forecast
- 6.2 Immunosuppressants
- 6.2.1 Market Trends
- 6.2.2 Major Types
- 6.2.2.1 Aubagio
- 6.2.2.2 Lemtrada
- 6.2.2.3 Ocrelizumab
- 6.2.2.4 Zinbryta
- 6.2.3 Market Forecast
7 Market Breakup by Drug Type
- 7.1 Biologic Drugs
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Small Molecule Drugs
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
8 Market Breakup by Route of Administration
- 8.1 Oral
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Injectable
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Intravenous
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
9 Market Breakup by Distribution Channel
- 9.1 Hospital Pharmacies
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
- 9.2 Retail Pharmacies
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
- 9.3 Online Pharmacies
- 9.3.1 Market Trends
- 9.3.2 Market Forecast
10 Market Breakup by Region
- 10.1 North America
- 10.1.1 United States
- 10.1.1.1 Market Trends
- 10.1.1.2 Market Forecast
- 10.1.2 Canada
- 10.1.2.1 Market Trends
- 10.1.2.2 Market Forecast
- 10.1.1 United States
- 10.2 Asia Pacific
- 10.2.1 China
- 10.2.1.1 Market Trends
- 10.2.1.2 Market Forecast
- 10.2.2 Japan
- 10.2.2.1 Market Trends
- 10.2.2.2 Market Forecast
- 10.2.3 India
- 10.2.3.1 Market Trends
- 10.2.3.2 Market Forecast
- 10.2.4 South Korea
- 10.2.4.1 Market Trends
- 10.2.4.2 Market Forecast
- 10.2.5 Australia
- 10.2.5.1 Market Trends
- 10.2.5.2 Market Forecast
- 10.2.6 Indonesia
- 10.2.6.1 Market Trends
- 10.2.6.2 Market Forecast
- 10.2.7 Others
- 10.2.7.1 Market Trends
- 10.2.7.2 Market Forecast
- 10.2.1 China
- 10.3 Europe
- 10.3.1 Germany
- 10.3.1.1 Market Trends
- 10.3.1.2 Market Forecast
- 10.3.2 France
- 10.3.2.1 Market Trends
- 10.3.2.2 Market Forecast
- 10.3.3 United Kingdom
- 10.3.3.1 Market Trends
- 10.3.3.2 Market Forecast
- 10.3.4 Italy
- 10.3.4.1 Market Trends
- 10.3.4.2 Market Forecast
- 10.3.5 Spain
- 10.3.5.1 Market Trends
- 10.3.5.2 Market Forecast
- 10.3.6 Russia
- 10.3.6.1 Market Trends
- 10.3.6.2 Market Forecast
- 10.3.7 Others
- 10.3.7.1 Market Trends
- 10.3.7.2 Market Forecast
- 10.3.1 Germany
- 10.4 Latin America
- 10.4.1 Brazil
- 10.4.1.1 Market Trends
- 10.4.1.2 Market Forecast
- 10.4.2 Mexico
- 10.4.2.1 Market Trends
- 10.4.2.2 Market Forecast
- 10.4.3 Others
- 10.4.3.1 Market Trends
- 10.4.3.2 Market Forecast
- 10.4.1 Brazil
- 10.5 Middle East and Africa
- 10.5.1 Market Trends
- 10.5.2 Market Breakup by Country
- 10.5.3 Market Forecast
11 SWOT Analysis
- 11.1 Overview
- 11.2 Strengths
- 11.3 Weaknesses
- 11.4 Opportunities
- 11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
- 13.1 Overview
- 13.2 Bargaining Power of Buyers
- 13.3 Bargaining Power of Suppliers
- 13.4 Degree of Competition
- 13.5 Threat of New Entrants
- 13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
- 15.1 Market Structure
- 15.2 Key Players
- 15.3 Profiles of Key Players
- 15.3.1 Abbvie Inc.
- 15.3.1.1 Company Overview
- 15.3.1.2 Product Portfolio
- 15.3.1.3 Financials
- 15.3.1.4 SWOT Analysis
- 15.3.2 Bayer Aktiengesellschaft
- 15.3.2.1 Company Overview
- 15.3.2.2 Product Portfolio
- 15.3.2.3 Financials
- 15.3.2.4 SWOT Analysis
- 15.3.3 Biogen Inc.
- 15.3.3.1 Company Overview
- 15.3.3.2 Product Portfolio
- 15.3.3.3 Financials
- 15.3.3.4 SWOT Analysis
- 15.3.4 Bristol-Myers Squibb Company
- 15.3.4.1 Company Overview
- 15.3.4.2 Product Portfolio
- 15.3.4.3 Financials
- 15.3.4.4 SWOT Analysis
- 15.3.5 F. Hoffmann-La Roche AG (Roche Holding AG)
- 15.3.5.1 Company Overview
- 15.3.5.2 Product Portfolio
- 15.3.5.3 SWOT Analysis
- 15.3.6 GlaxoSmithKline Plc
- 15.3.6.1 Company Overview
- 15.3.6.2 Product Portfolio
- 15.3.6.3 Financials
- 15.3.6.4 SWOT Analysis
- 15.3.7 Merck & Co. Inc.
- 15.3.7.1 Company Overview
- 15.3.7.2 Product Portfolio
- 15.3.7.3 Financials
- 15.3.7.4 SWOT Analysis
- 15.3.8 Novartis AG
- 15.3.8.1 Company Overview
- 15.3.8.2 Product Portfolio
- 15.3.8.3 Financials
- 15.3.8.4 SWOT Analysis
- 15.3.9 Sanofi S.A.
- 15.3.9.1 Company Overview
- 15.3.9.2 Product Portfolio
- 15.3.9.3 Financials
- 15.3.9.4 SWOT Analysis
- 15.3.10 Teva Pharmaceutical Industries Ltd.
- 15.3.10.1 Company Overview
- 15.3.10.2 Product Portfolio
- 15.3.10.3 Financials
- 15.3.10.4 SWOT Analysis
- 15.3.1 Abbvie Inc.
Product Code: SR112025A2571
List of Figures
- Figure 1: Global: Multiple Sclerosis Therapies Market: Major Drivers and Challenges
- Figure 2: Global: Multiple Sclerosis Therapies Market: Sales Value (in Billion USD), 2019-2024
- Figure 3: Global: Multiple Sclerosis Therapies Market: Breakup by Drug (in %), 2024
- Figure 4: Global: Multiple Sclerosis Therapies Market: Breakup by Drug Type (in %), 2024
- Figure 5: Global: Multiple Sclerosis Therapies Market: Breakup by Route of Administration (in %), 2024
- Figure 6: Global: Multiple Sclerosis Therapies Market: Breakup by Distribution Channel (in %), 2024
- Figure 7: Global: Multiple Sclerosis Therapies Market: Breakup by Region (in %), 2024
- Figure 8: Global: Multiple Sclerosis Therapies Market Forecast: Sales Value (in Billion USD), 2025-2033
- Figure 9: Global: Multiple Sclerosis Therapies (Immunomodulators) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 10: Global: Multiple Sclerosis Therapies (Immunomodulators) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 11: Global: Multiple Sclerosis Therapies (Immunosuppressants) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 12: Global: Multiple Sclerosis Therapies (Immunosuppressants) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 13: Global: Multiple Sclerosis Therapies (Biologic Drugs) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 14: Global: Multiple Sclerosis Therapies (Biologic Drugs) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 15: Global: Multiple Sclerosis Therapies (Small Molecule Drugs) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 16: Global: Multiple Sclerosis Therapies (Small Molecule Drugs) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 17: Global: Multiple Sclerosis Therapies (Oral) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 18: Global: Multiple Sclerosis Therapies (Oral) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 19: Global: Multiple Sclerosis Therapies (Injectable) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 20: Global: Multiple Sclerosis Therapies (Injectable) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 21: Global: Multiple Sclerosis Therapies (Intravenous) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 22: Global: Multiple Sclerosis Therapies (Intravenous) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 23: Global: Multiple Sclerosis Therapies (Hospital Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 24: Global: Multiple Sclerosis Therapies (Hospital Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 25: Global: Multiple Sclerosis Therapies (Retail Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 26: Global: Multiple Sclerosis Therapies (Retail Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 27: Global: Multiple Sclerosis Therapies (Online Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 28: Global: Multiple Sclerosis Therapies (Online Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 29: North America: Multiple Sclerosis Therapies Market: Sales Value (in Million USD), 2019 & 2024
- Figure 30: North America: Multiple Sclerosis Therapies Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 31: United States: Multiple Sclerosis Therapies Market: Sales Value (in Million USD), 2019 & 2024
- Figure 32: United States: Multiple Sclerosis Therapies Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 33: Canada: Multiple Sclerosis Therapies Market: Sales Value (in Million USD), 2019 & 2024
- Figure 34: Canada: Multiple Sclerosis Therapies Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 35: Asia Pacific: Multiple Sclerosis Therapies Market: Sales Value (in Million USD), 2019 & 2024
- Figure 36: Asia Pacific: Multiple Sclerosis Therapies Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 37: China: Multiple Sclerosis Therapies Market: Sales Value (in Million USD), 2019 & 2024
- Figure 38: China: Multiple Sclerosis Therapies Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 39: Japan: Multiple Sclerosis Therapies Market: Sales Value (in Million USD), 2019 & 2024
- Figure 40: Japan: Multiple Sclerosis Therapies Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 41: India: Multiple Sclerosis Therapies Market: Sales Value (in Million USD), 2019 & 2024
- Figure 42: India: Multiple Sclerosis Therapies Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 43: South Korea: Multiple Sclerosis Therapies Market: Sales Value (in Million USD), 2019 & 2024
- Figure 44: South Korea: Multiple Sclerosis Therapies Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 45: Australia: Multiple Sclerosis Therapies Market: Sales Value (in Million USD), 2019 & 2024
- Figure 46: Australia: Multiple Sclerosis Therapies Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 47: Indonesia: Multiple Sclerosis Therapies Market: Sales Value (in Million USD), 2019 & 2024
- Figure 48: Indonesia: Multiple Sclerosis Therapies Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 49: Others: Multiple Sclerosis Therapies Market: Sales Value (in Million USD), 2019 & 2024
- Figure 50: Others: Multiple Sclerosis Therapies Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 51: Europe: Multiple Sclerosis Therapies Market: Sales Value (in Million USD), 2019 & 2024
- Figure 52: Europe: Multiple Sclerosis Therapies Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 53: Germany: Multiple Sclerosis Therapies Market: Sales Value (in Million USD), 2019 & 2024
- Figure 54: Germany: Multiple Sclerosis Therapies Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 55: France: Multiple Sclerosis Therapies Market: Sales Value (in Million USD), 2019 & 2024
- Figure 56: France: Multiple Sclerosis Therapies Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 57: United Kingdom: Multiple Sclerosis Therapies Market: Sales Value (in Million USD), 2019 & 2024
- Figure 58: United Kingdom: Multiple Sclerosis Therapies Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 59: Italy: Multiple Sclerosis Therapies Market: Sales Value (in Million USD), 2019 & 2024
- Figure 60: Italy: Multiple Sclerosis Therapies Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 61: Spain: Multiple Sclerosis Therapies Market: Sales Value (in Million USD), 2019 & 2024
- Figure 62: Spain: Multiple Sclerosis Therapies Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 63: Russia: Multiple Sclerosis Therapies Market: Sales Value (in Million USD), 2019 & 2024
- Figure 64: Russia: Multiple Sclerosis Therapies Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 65: Others: Multiple Sclerosis Therapies Market: Sales Value (in Million USD), 2019 & 2024
- Figure 66: Others: Multiple Sclerosis Therapies Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 67: Latin America: Multiple Sclerosis Therapies Market: Sales Value (in Million USD), 2019 & 2024
- Figure 68: Latin America: Multiple Sclerosis Therapies Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 69: Brazil: Multiple Sclerosis Therapies Market: Sales Value (in Million USD), 2019 & 2024
- Figure 70: Brazil: Multiple Sclerosis Therapies Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 71: Mexico: Multiple Sclerosis Therapies Market: Sales Value (in Million USD), 2019 & 2024
- Figure 72: Mexico: Multiple Sclerosis Therapies Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 73: Others: Multiple Sclerosis Therapies Market: Sales Value (in Million USD), 2019 & 2024
- Figure 74: Others: Multiple Sclerosis Therapies Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 75: Middle East and Africa: Multiple Sclerosis Therapies Market: Sales Value (in Million USD), 2019 & 2024
- Figure 76: Middle East and Africa: Multiple Sclerosis Therapies Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 77: Global: Multiple Sclerosis Therapies Industry: SWOT Analysis
- Figure 78: Global: Multiple Sclerosis Therapies Industry: Value Chain Analysis
- Figure 79: Global: Multiple Sclerosis Therapies Industry: Porter's Five Forces Analysis
List of Tables
- Table 1: Global: Multiple Sclerosis Therapies Market: Key Industry Highlights, 2024 and 2033
- Table 2: Global: Multiple Sclerosis Therapies Market Forecast: Breakup by Drug (in Million USD), 2025-2033
- Table 3: Global: Multiple Sclerosis Therapies Market Forecast: Breakup by Drug Type (in Million USD), 2025-2033
- Table 4: Global: Multiple Sclerosis Therapies Market Forecast: Breakup by Route of Administration (in Million USD), 2025-2033
- Table 5: Global: Multiple Sclerosis Therapies Market Forecast: Breakup by Distribution Channel (in Million USD), 2025-2033
- Table 6: Global: Multiple Sclerosis Therapies Market Forecast: Breakup by Region (in Million USD), 2025-2033
- Table 7: Global: Multiple Sclerosis Therapies Market Structure
- Table 8: Global: Multiple Sclerosis Therapies Market: Key Player
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.